ask="N/A"
ask_size="N/A"
average_daily_volume="19822"
bid="1.96"
bid_size="100"
book_value="0.38"
change="+0.00"
change_from_200_day_moving_average="0.03"
change_from_50_day_moving_average="0.01"
change_from_52_week_high="-0.42"
change_From_52_week_low="0.95"
change_in_percent="+0.00%"
close="2.03"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-0.21"
ebitda="-2.96M"
eps_estimate_current_year="N/A"
eps_estimate_next_quarter="0.00"
eps_estimate_next_year="N/A"
ex_dividend_date="N/A"
float_shares="10636000"
high="2.03"
high_52_weeks="2.45"
last_trade_date="3/7/2017"
last_trade_price="2.03"
last_trade_size="100"
last_trade_time="4:00pm"
low="2.03"
low_52_weeks="1.08"
market_capitalization="34.67M"
moving_average_200_day="2.00"
moving_average_50_day="2.02"
name="ProPhase Labs
Inc."
notes="N/A"
one_year_target_price="15.55"
open="2.06"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="+1.55%"
percent_change_from_50_day_moving_average="+0.38%"
percent_change_from_52_week_high="-17.14%"
percent_change_from_52_week_low="+87.96%"
previous_close="2.03"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="5.30"
price_per_sales="1.61"
revenue="21.57M"
shares_outstanding="17080000"
short_ratio="0.13"
stock_exchange="NCM"
symbol="PRPH"
volume="700"
weeks_range_52="1.08 - 2.45"
